Mark T. Osterman, M.D., MSCE
Mark T. Osterman, M.D., MSCE
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania and the Presbyterian Medical Center of Philadelphia
Department: Medicine
Contact information
Penn Presbyterian Medical Center
Division of Gastroenterology
218 Wright-Saunders Building
51 N 39th Street
Philadelphia, PA 19104
Division of Gastroenterology
218 Wright-Saunders Building
51 N 39th Street
Philadelphia, PA 19104
Office: 215-662-8900
Fax: 215-662-0950
Fax: 215-662-0950
Email:
mark.osterman@uphs.upenn.edu
mark.osterman@uphs.upenn.edu
Publications
Education:
BA (Chemistry)
Harvard University, 1995.
MD (Medicine)
Harvard Medical School, 1999.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2005.
Permanent linkBA (Chemistry)
Harvard University, 1995.
MD (Medicine)
Harvard Medical School, 1999.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2005.
Selected Publications
Aberra FN, Osterman MT, Buchner A, Lewis JD: Can Colonoscopy Reduce the Risk of Colon Cancer and Mortality in Patients with Inflammatory Bowel Disease? Clinical Gastroenterology and Hepatology 2015 Notes: In press.Vajravelu RK, Lewis JD, Osterman MT, Aberra F, Lichtenstein GR, Scott FI: Predictors of Indeterminate QuantiFERON-TB Gold Testing in Inflammatory Bowel Disease and Impact on Clinical Outcomes. Gastroenterology 2015 Notes: In press.
Osterman MT, Haynes K, Delzell E, Zhang J, Bewtra M, Brensinger CM, Chen L, Xie F, Curtis JR, Lewis JD: Effectiveness and Safety of Immunomodulators with Anti-TNF Therapy in Crohn's Disease. Clinical Gastroenterology and Hepatology 2015 Notes: In press.
Osterman MT: Reply. Clinical Gastroenterology and Hepatology 2014 Notes: In press.
Osterman MT, Sandborn WJ, Colombel J-F, Robinson AM, Lau W, Huang B, Pollack PF, Thakkar T, Lewis JD. : Increased risk of malignancy with adalimumab combination therapy, compared to monotherapy, in Crohn’s disease. Gastroenterology (146), 941-9, 2014.
Osterman MT, Haynes K, Delzell E, Zhang J, Bewtra M, Brensinger C, Chen L, Xie F, Curtis JR, Lewis JD. : Comparative effectiveness of infliximab and adalimumab for Crohn’s disease. Clinical Gastroenterology and Hepatology 12: 811-7, 2014.
Osterman MT. Lichtenstein GR. : Ulcerative colitis. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease, 10th Edition. Feldman M, Friedman LS, Brandt LJ (eds.). Saunders Elsevier, Philadelphia, 2014 Notes: In press.
Wangensteen KJ, Fogt F, Kann BR, Osterman MT: Idiopathic Myointimal Hyperplasia of the Mesenteric Veins Diagnosed Preoperatively: Case Report and Review of the Literature. Journal of Clinical Gastroenterology 2014 Notes: In press.
Osterman MT, study authors.: Reply. Gastroenterolgoy 147: 540-1, 2014.
Osterman MT, Aberra FN, Cross R, Liakos S, McCabe R, Sharfan I, Wolf D, Hardi R, Nessel L, Brensinger C, Gilroy E, Lewis JD. : A randomized controlled trial of mesalamine dose escalation for ulcerative colitis in remission. Gastroenterology 146(Suppl1): S-149, 2014 Notes: Oral presentation.